Header Logo

Connection

CATHERINE HEALY to Humans

Back to Details
This is a "connection" page, showing publications CATHERINE HEALY has written about Humans.
CATHERINE HEALY
Connection Strength
0.648
Humans
  1. Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0.025
  2. Safety and Benefits of COVID-19 Vaccination in Pregnancy-Implications for the Maternal Vaccination Platform. JAMA Pediatr. 2023 12 01; 177(12):1261-1263.
    View in: PubMed
    Score: 0.024
  3. mRNA vaccines against respiratory viruses. Curr Opin Infect Dis. 2023 10 01; 36(5):385-393.
    View in: PubMed
    Score: 0.023
  4. Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series. Clin Infect Dis. 2023 02 08; 76(3):e1087-e1093.
    View in: PubMed
    Score: 0.023
  5. Immune Response to SARS-CoV-2 Infection in Children. JAMA Pediatr. 2022 11 01; 176(11):1075-1076.
    View in: PubMed
    Score: 0.022
  6. Medical ethics principles underscore advocating for human papillomavirus vaccine. Hum Vaccin Immunother. 2022 12 31; 18(1):1989926.
    View in: PubMed
    Score: 0.021
  7. COVID-19 in Pregnant Women and Their Newborn Infants. JAMA Pediatr. 2021 08 01; 175(8):781-783.
    View in: PubMed
    Score: 0.020
  8. Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy. Vaccine. 2020 08 18; 38(37):5955-5961.
    View in: PubMed
    Score: 0.019
  9. How Important Is the Type of Acellular Pertussis Vaccine? Clin Infect Dis. 2020 01 02; 70(2):208-209.
    View in: PubMed
    Score: 0.018
  10. Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration. JAMA. 2018 10 09; 320(14):1464-1470.
    View in: PubMed
    Score: 0.017
  11. Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy. Vaccine. 2015 Oct 05; 33(41):5445-5451.
    View in: PubMed
    Score: 0.014
  12. Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center. Vaccine. 2015 Sep 11; 33(38):4983-7.
    View in: PubMed
    Score: 0.013
  13. Reply to L'Huillier et al. Am J Transplant. 2015 Aug; 15(8):2277.
    View in: PubMed
    Score: 0.013
  14. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant. 2015 Feb; 15(2):535-40.
    View in: PubMed
    Score: 0.013
  15. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015 Jan; 34(1):22-6.
    View in: PubMed
    Score: 0.013
  16. Commentary on "Parental vaccine-hesitancy: Understanding the problem and searching for a resolution". Hum Vaccin Immunother. 2014; 10(9):2597-9.
    View in: PubMed
    Score: 0.013
  17. Acceptability of immunization in adult contacts of infants: possibility of expanding platforms to increase adult vaccine uptake. Vaccine. 2014 May 07; 32(22):2540-5.
    View in: PubMed
    Score: 0.012
  18. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
    View in: PubMed
    Score: 0.012
  19. Parent and provider perspectives on immunization: are providers overestimating parental concerns? Vaccine. 2014 Jan 23; 32(5):579-84.
    View in: PubMed
    Score: 0.012
  20. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother. 2013 Sep; 9(9):1926-31.
    View in: PubMed
    Score: 0.012
  21. Reply to Leuridan et al. Clin Infect Dis. 2013 Aug; 57(3):472-3.
    View in: PubMed
    Score: 0.011
  22. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis. 2013 Feb; 56(4):539-44.
    View in: PubMed
    Score: 0.011
  23. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol. 2012 Jun; 55(2):474-86.
    View in: PubMed
    Score: 0.011
  24. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol. 2013 Jan; 33(1):52-8.
    View in: PubMed
    Score: 0.011
  25. Infant pertussis: what to do next? Clin Infect Dis. 2012 Feb 01; 54(3):328-30.
    View in: PubMed
    Score: 0.010
  26. How to communicate with vaccine-hesitant parents. Pediatrics. 2011 May; 127 Suppl 1:S127-33.
    View in: PubMed
    Score: 0.010
  27. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011 Jan 15; 52(2):157-62.
    View in: PubMed
    Score: 0.010
  28. Pertussis immunization in a high-risk postpartum population. Vaccine. 2009 Sep 18; 27(41):5599-602.
    View in: PubMed
    Score: 0.009
  29. Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J. 2009 Jan; 28(1):49-52.
    View in: PubMed
    Score: 0.009
  30. The cocoon strategy. Tex Med. 2008 Aug; 104(8):3.
    View in: PubMed
    Score: 0.008
  31. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics. 2008 Apr; 121(4):703-10.
    View in: PubMed
    Score: 0.008
  32. Maternal immunization. Pediatr Infect Dis J. 2007 Oct; 26(10):945-8.
    View in: PubMed
    Score: 0.008
  33. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis. 2006 Jun; 19(3):271-6.
    View in: PubMed
    Score: 0.007
  34. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006 May 15; 42(10):1439-42.
    View in: PubMed
    Score: 0.007
  35. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005 Aug; 147(2):166-71.
    View in: PubMed
    Score: 0.007
  36. What's Old Is New Again: Measles. Pediatrics. 2025 Jun 01; 155(6).
    View in: PubMed
    Score: 0.007
  37. Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials. JAMA Netw Open. 2025 May 01; 8(5):e2512763.
    View in: PubMed
    Score: 0.007
  38. The future of meningococcal vaccines. Pediatr Infect Dis J. 2005 Feb; 24(2):175-6.
    View in: PubMed
    Score: 0.007
  39. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004 Nov 15; 39(10):1460-6.
    View in: PubMed
    Score: 0.006
  40. Features of invasive staphylococcal disease in neonates. Pediatrics. 2004 Oct; 114(4):953-61.
    View in: PubMed
    Score: 0.006
  41. COVID-19 Vaccine Hesitancy in Caregivers of Hospitalized Children From 2020 Through 2023. Hosp Pediatr. 2024 09 01; 14(9):701-713.
    View in: PubMed
    Score: 0.006
  42. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004 Jul 15; 190(2):335-40.
    View in: PubMed
    Score: 0.006
  43. SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Netw Open. 2024 05 01; 7(5):e2412835.
    View in: PubMed
    Score: 0.006
  44. Risk of COVID-19 after natural infection or vaccination. EBioMedicine. 2023 Oct; 96:104799.
    View in: PubMed
    Score: 0.006
  45. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med. 2023 09; 29(9):2334-2346.
    View in: PubMed
    Score: 0.006
  46. Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2023 07 03; 6(7):e2323349.
    View in: PubMed
    Score: 0.006
  47. Parents' stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors. Hum Vaccin Immunother. 2023 12 31; 19(1):2214054.
    View in: PubMed
    Score: 0.006
  48. Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA Netw Open. 2023 01 03; 6(1):e2251974.
    View in: PubMed
    Score: 0.006
  49. Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age. N Engl J Med. 2022 11 03; 387(18):1673-1687.
    View in: PubMed
    Score: 0.006
  50. Group B Streptococcal Cellulitis-Adenitis Syndrome in Infants: Insights From 24 Years of Experience. J Pediatric Infect Dis Soc. 2022 Aug 30; 11(8):375-378.
    View in: PubMed
    Score: 0.006
  51. An eighteenth-century disease in the year 2001. Semin Pediatr Infect Dis. 2002 Jul; 13(3):147, 232-4.
    View in: PubMed
    Score: 0.005
  52. AVPCancerFree: Impact of a digital behavior change intervention on parental HPV vaccine -related perceptions and behaviors. Hum Vaccin Immunother. 2022 11 30; 18(5):2087430.
    View in: PubMed
    Score: 0.005
  53. Parent Engagement with a Self-Tailored Cancer Prevention Digital Behavior Change Intervention: Exploratory Application of Affiliation Network Analysis. Stud Health Technol Inform. 2022 Jun 06; 290:819-823.
    View in: PubMed
    Score: 0.005
  54. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. N Engl J Med. 2022 05 26; 386(21):2011-2023.
    View in: PubMed
    Score: 0.005
  55. Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000. Clin Infect Dis. 2002 May 15; 34(10):1323-30.
    View in: PubMed
    Score: 0.005
  56. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 2022 Feb 10; 386(6):531-543.
    View in: PubMed
    Score: 0.005
  57. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 04; 385(19):1774-1785.
    View in: PubMed
    Score: 0.005
  58. Antenatal hepatitis B screening - is there a need for a national policy? Ir Med J. 2001 Apr; 94(4):111-2, 114.
    View in: PubMed
    Score: 0.005
  59. Outcome of infants born to hepatitis C infected women. Ir J Med Sci. 2001 Apr-Jun; 170(2):103-6; discussion 92-3.
    View in: PubMed
    Score: 0.005
  60. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 02 04; 384(5):403-416.
    View in: PubMed
    Score: 0.005
  61. Hepatitis C infection in an Irish antenatal population. Ir J Med Sci. 2000 Jul-Sep; 169(3):180-2.
    View in: PubMed
    Score: 0.005
  62. Trichosporonosis in Pediatric Patients With a Hematologic Disorder. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):199-204.
    View in: PubMed
    Score: 0.004
  63. A 3-Week-Old With an Isolated "Blueberry Muffin" Rash. Pediatrics. 2017 Jul; 140(1).
    View in: PubMed
    Score: 0.004
  64. A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain. Allergy Asthma Proc. 2015 Sep-Oct; 36(5):407-11.
    View in: PubMed
    Score: 0.003
  65. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 07; 311(17):1760-9.
    View in: PubMed
    Score: 0.003
  66. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012 Jan 01; 54(1):78-84.
    View in: PubMed
    Score: 0.003
  67. Unusual soft tissue manifestations of Neisseria meningitidis infections. Clin Pediatr (Phila). 2008 May; 47(4):400-3.
    View in: PubMed
    Score: 0.002
  68. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 2003 Dec; 4(8):533-40.
    View in: PubMed
    Score: 0.002
  69. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. Int J STD AIDS. 2000 Apr; 11(4):220-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.